Journal
TUMOR BIOLOGY
Volume 35, Issue 12, Pages 12173-12180Publisher
SPRINGER
DOI: 10.1007/s13277-014-2525-5
Keywords
Breast cancer; Circulating microRNA; tRNA-derived fragment; Biomarker; Cancer-associated microRNAs
Categories
Funding
- NCC [0910220, 1110260]
Ask authors/readers for more resources
Cancer-associated microRNAs have been stably detected in blood. The objective of this study was to identify a panel of circulating microRNAs with the potential to serve as biomarkers for estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2 (HER2)- breast cancer. We used microarray-based expression profiling to compare the levels of circulating microRNAs in blood samples from 11 ER+/HER2- advanced breast cancer patients plus 5 age-matched controls. MicroRNA levels were validated by reverse transcription quantitative polymerase chain reaction in 40 control subjects, 187 early breast cancer patients, and 45 metastatic breast cancer patients. Then, we assessed the association between the levels of microRNA and clinical outcomes of ER+/HER2- metastatic breast cancer. Initially, we found that miR-1280, miR-1260, and miR-720 were up-regulated in blood from breast cancer patients (P<0.05). In validation, miR-1280 levels significantly increased in breast cancer patients and reflected tumor status (control<
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available